| US 7,507,795 B2 | ||
| Murine ZCYTOR17 ligand polypeptides | ||
| Cindy A. Sprecher, Hereford, Ariz. (US); Joseph L. Kuijper, Kenmore, Wash. (US); Maria M. Dasovich, Seattle, Wash. (US); Francis J. Grant, Seattle, Wash. (US); Jane A. Gross, Seattle, Wash. (US); Angela K. Hammond, Kirkland, Wash. (US); and Rolf E. Kuestner, Bothell, Wash. (US) | ||
| Assigned to ZymoGenetics, Inc., Seattle, Wash. (US) | ||
| Filed on Dec. 13, 2006, as Appl. No. 11/610,126. | ||
| Application 11/610126 is a division of application No. 11/301764, filed on Dec. 13, 2005. | ||
| Application 11/301764 is a division of application No. 10/352554, filed on Jan. 21, 2003, granted, now 7,064,186. | ||
| Claims priority of provisional application 60/435315, filed on Dec. 19, 2002. | ||
| Claims priority of provisional application 60/375323, filed on Apr. 25, 2002. | ||
| Claims priority of provisional application 60/350325, filed on Jan. 18, 2002. | ||
| Prior Publication US 2007/0077627 A1, Apr. 05, 2007 | ||
| Int. Cl. C07K 14/52 (2006.01); C12N 15/63 (2006.01) | ||
| U.S. Cl. 530—351 [435/69.5] | 7 Claims |
| 1. An isolated polypeptide comprising the sequence of amino acid residues having at least 95% identity to:
(a) amino acid residues 31 to 163 as shown in SEQ ID NO:11; or
(b) amino acid residues 1 to 163 as shown in SEQ ID NO:11
wherein the polypeptide induces proinflammatory cytokine production.
|